Previous 10 | Next 10 |
Waters Corporation (WAT) has appointed Amol Chaubal as the senior vice president and chief financial officer, effective May 12, 2021.Michael Silveira who was the Interim Chief Financial Officer since January 2021 will return to his previous role as corporate controller and assume the rol...
NEWS SUMMARY: Amol Chaubal named Waters Chief Financial Officer Jonathan Pratt named Senior Vice President of new Waters Division Jianqing Bennett named Senior Vice President of TA Instruments Division Mike Harrington, Senior Vice President of Global Markets, and I...
No matter what industry we are talking about, political decisions, and policy changes can affect the price of the stocks in that industry, and Waters (NYSE: WAT) is not an exception. WAT like every other company, it will experience ebbs and flows based on this type of news too, so...
A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. A list of cheap stocks. Short review of IDNA. For further details see: Healthcare Dashboard For April And Focus On IDNA
Firms Working to Co-Develop Automated Biotherapeutic Characterization Workflows, Combining Waters LC-MS Instrumentation and Genovis SmartEnzymes NEWS SUMMARY: Collaboration intended to bring speed and simplicity to bio-characterization workflows Automated workflows...
Waters Corporation (NYSE:WAT) will webcast its Q1 2021 financial results conference call live on Wednesday, May 5 th , 2021 at 8:00 a.m. eastern time. To listen to the conference call, connect to Waters’ website, www.waters.com choose “Investors” and cli...
Waters Corporation (NYSE:WAT) traded today at a new 52-week high of $305.58. This new high was reached on below average trading volume as 118,000 shares traded hands, while the average 30-day volume is approximately 388,000 shares. Water sells liquid chromatography, mass spectrometry, an...
Agilent isn't a conventionally cheap stock, but should offer above-average revenue growth and margin expansion over the next five to 10 years, with leverage to several growth segments with biopharma. Agilent has been gaining share in instruments and demand should improve as lab activi...
Investors in Waters (NYSE: WAT) like to make good decisions, that means they like to buy and sell at the right times, and to do that the best tools involve charts, pivot points, and the technical data. Below, we have provided a snapshot for WAT that reveals this information a...
Technical analysis provides insights that fundamental observations cannot. We can use that to our advantage in Waters (NYSE: WAT). Using the data offered below we have a real-time example. Review The technical data for WAT below, and the added value of technical ...
News, Short Squeeze, Breakout and More Instantly...
Waters Corporation (NYSE: WAT) Reports Second Quarter 2024 Financial Results PR Newswire Highlights Sales of $709 million exceeded guidance on a reported basis, declined 4% as reported and 4% in organic constant currency GAAP EPS of $2.40 ; earnin...
Waters New Rapid Screening-DSC Enables Up to 24x Faster Thermal Stability Testing at Ultra-Low Sample Volumes for Antibody Drugs PR Newswire News Summary: Reduces sample volume requirements by 25x through use of advanced microfluidic technologies while increasing throu...
Waters Corporation Schedules Second Quarter 2024 Earnings Conference Call PR Newswire MILFORD, Mass. , July 2, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q2 2024 financial results conference call live on Wednesday, July 31st, 2024 at 8...